15260232

Source:http://linkedlifedata.com/resource/pubmed/id/15260232

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007226, umls-concept:C0017296, umls-concept:C0599894, umls-concept:C1520007, umls-concept:C1521840, umls-concept:C1527148
pubmed:dateCreated	2004-7-20
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7907340
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:issn	0196-3716
pubmed:author	pubmed-author:BakerAndrew HAH, pubmed-author:NicklinStuart ASA
pubmed:issnType	Print
pubmed:volume	25
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	15-49
pubmed:dateRevised	2006-4-21
pubmed:meshHeading	pubmed-meshheading:15260232-Animals, pubmed-meshheading:15260232-Cardiovascular Diseases, pubmed-meshheading:15260232-Gene Therapy, pubmed-meshheading:15260232-Genetic Vectors, pubmed-meshheading:15260232-Humans
pubmed:year	2003
pubmed:articleTitle	Development of targeted viral vectors for cardiovascular gene therapy.
pubmed:affiliation	British Heart Foundation Blood Pressure Group, Division of Cardiovascular and Medical Sciences, University of Glasgow, Western Infirmary, Glasgow G11 6NT, UK.
pubmed:publicationType	Journal Article, Review